Archive for year: 2024

Cognivue® to Partner on Another Major Clinical Study with the Global Alzheimer’s Platform Foundation

October 30, 2024

Cognivue Clarity^®, a non-invasive and repeatable digital cognitive assessment tool that can assess cognitive functioning and amyloid presence, will be evaluated in the Bio-Hermes-002 study.
October 30, 2024
Cognivue, Inc. announces strategic partnership with the Global Alzheimer’s Platform (GAP) as we participate in the Bio-Hermes-002 clinical trial study. As a GAP study partner, Cognivue will join Biogen and other participating...

Cognivue Names Paul W. Estes as President— Promotion of Company Veteran Reflects Neuroscience Technology Developer’s Next Evolutionary Stage

April 22, 2024

Neuroscience technology innovator Cognivue, Inc. announced today that Paul W. Estes has been promoted to president, ushering in the company’s next stage of market evolution. He will guide the executive leadership team and oversee the company’s technology roadmap planning, new product expansion, partnership relations, sales, and staffing....

Schedule a Cognivue DEMO Today